Reuters logo
2 个月内
BRIEF-Soligenix says publication of phase 2 long-term follow-up results of SGX942
2017年5月18日 / 上午10点13分 / 2 个月内

BRIEF-Soligenix says publication of phase 2 long-term follow-up results of SGX942

1 分钟阅读

May 18 (Reuters) - Soligenix Inc:

* Soligenix announces publication of its phase 2 long-term follow-up results of SGX942 for the treatment of oral mucositis in head and neck cancer patients

* Says SGX942 found to be safe and well tolerated with multiple potential ancillary benefits Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below